Use of multivariate models to improve prediction of pathologic stage for men with clinically localized prostate cancer

被引：0

作者：

TJ Polascik

JD Pearson

AW Partin

Dr TJ Polascik

机构：

[1] James Buchanan Brady Urological Institute,

[2] The Johns Hopkins Medical Institutions,undefined

[3] Merck Research Laboratories,undefined

来源：

Prostate Cancer and Prostatic Diseases | 1998年 / 1卷

关键词：

prostate cancer; PSA; multivariate analysis; nomogram; staging;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

To benefit from definitive local therapy, men with clinically localized prostate cancer should have organ-confined disease. We discuss the use of multivariate analysis using serum PSA, biopsy Gleason score and clinical stage to improve the prediction of pathologic stage.

引用

页码：301 / 306

页数：5

共 50 条

[31] Brachytherapy in men aged ≤54 years with clinically localized prostate cancer
Merrick, Gregory S.
Wallner, Kent E.
Butler, Wayne M.
Galbreatho, Robert W.
Allen, Zachariah A.
Adamovich, Edward
True, Lawrence
BJU INTERNATIONAL, 2006, 98 (02) : 324 - 328
[32] Is race a surrogate for the differences in income in men with clinically localized prostate cancer?
Tewari, A
Hasan, M
Wei, JT
Devine, G
Menon, M
JOURNAL OF UROLOGY, 2004, 171 (04): : 36 - 36
[33] Pathological and Oncological Outcomes of Elderly Men with Clinically Localized Prostate Cancer
Mitsuzuka, Koji
Koie, Takuya
Narita, Shintaro
Kaiho, Yasuhiro
Yoneyama, Takahiro
Tsuchiya, Norihiko
Kakoi, Narihiko
Kawamura, Sadafumi
Tochigi, Tatsuo
Ohyama, Chikara
Habuchi, Tomonori
Arai, Yoichi
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2013, 43 (12) : 1238 - 1242
[34] Association of prostate size and tumor grade in Korean men with clinically localized prostate cancer
Hong, Sung Kyu
Yu, Ji Hyung
Han, Byung Kyu
Chang, In Ho
Jeong, Seong Jin
Byun, Seok-Soo
Lee, Hak Jong
Choe, Gheeyoung
Lee, Sang Eun
UROLOGY, 2007, 70 (01) : 91 - 95
[35] Prostate cancer mortality after radical prostatectomy or radiation therapy in men with clinically localized prostate cancer
Wu, HY
Moul, JW
Sun, L
McLeod, DG
Amling, CL
Donahue, TF
Kusuda, L
Sexton, WJ
Reilly, KJ
Hernandez, J
Chung, A
Smith, K
JOURNAL OF UROLOGY, 2004, 171 (04): : 118 - 118
[36] Weight change, obesity and risk of prostate cancer progression among men with clinically localized prostate cancer
Dickerman, Barbra A.
Ahearn, Thomas U.
Giovannucci, Edward
Stampfer, Meir J.
Nguyen, Paul L.
Mucci, Lorelei A.
Wilson, Kathryn M.
INTERNATIONAL JOURNAL OF CANCER, 2017, 141 (05) : 933 - 944
[37] Insurance status is a determinant of the stage at presentation and of cancer control in european men subjected to radical prostatectomy for clinically localized prostate cancer
Gallina, A.
P. I., Karakiewicz
Walz, J.
Chun, F. K.
Briganti, A.
Deho', F.
Ahyai, S.
Zanni, G.
Michl, U.
Haese, A.
Valiquette, L.
Rigatti, P.
Montorsi, F.
Graefen, M.
Huland, H.
EUROPEAN UROLOGY SUPPLEMENTS, 2007, 6 (02) : 181 - 181
[38] Predictive Models in External Beam Radiotherapy for Clinically Localized Prostate Cancer
Roach, Mack, III
Waldman, Fred
Pollack, Alan
CANCER, 2009, 115 (13) : 3112 - 3120
[39] PROSTATE CANCER MORTALITY IN MEN PARTICIPATING IN SCREENING: RISK ANALYSIS OF MEN MANAGED BY RADICAL SURGERY FOR CLINICALLY LOCALIZED PROSTATE CANCER
Van Leeuwen, P. J.
Van Den Bergh, R. C. N.
Tammela, T. L. J.
Kwiatkowski, M.
Denis, L.
Chiatto, S.
Hugosson, J.
Schroeder, F. H.
EUROPEAN UROLOGY SUPPLEMENTS, 2011, 10 (02) : 334 - 335
[40] SBRT for clinically localized prostate cancer in men with hip replacements: a cautionary note
Conroy, D.
Pepin, A.
Tsou, H.
Rashid, H.
Ayoob, M.
Danner, M.
Yung, T.
Collins, B.
Krishnan, P.
Lei, S.
Suy, S.
Kataria, S.
Aghdam, N.
Collins, S.
RADIOTHERAPY AND ONCOLOGY, 2022, 170 : S1208 - S1208

← 1 2 3 4 5 →